TY - JOUR
T1 - Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients
AU - Xu, He
AU - Lee, Hui Jie
AU - Schmitz, Robin
AU - Shaw, Brian I.
AU - Li, Shu
AU - Kirk, Allan D.
N1 - Funding Information:
The authors gratefully acknowledge Nicole Bissonnette for her assistance in tissue sample management and Ashely Morgan for her proof reading and editing. This work was funded in part by grants from the Roche Organ Transplant Research Foundation (346678023, HX) and the National Institutes of Health (AI097423, ADK). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2021/9
Y1 - 2021/9
N2 - Thymic output and homeostatic mature cell proliferation both influence T cell repopulation following depletional induction, though the relative contribution of each and their association with recipient age have not been well studied. We investigated the repopulating T cell kinetics in kidney transplant recipients who underwent alemtuzumab induction followed by belatacept/rapamycin-based immunosuppression over 36-month posttransplantation. We focused specifically on the correlation between repopulating T cell subsets and the age of patients. Substantial homeostatic Ki67-expressing T cell proliferation was seen posttransplantation. A repertoire enriched for naïve T (TNaïve) cells emerged posttransplantation. Analysis by generalized estimating equation linear models revealed a strong negative linear association between reconstituting TNaïve cells and advancing age. A relationship between age and persistence of effector memory cells was shown. We assessed thymic output and found an increase in the frequency of recent thymic emigrants (RTEs, CD4+CD31+) at 12-month posttransplantation. Patients under 30 years of age showed significantly higher levels of CD4+CD31+ cells than patients over 55 years of age pre- and posttransplantation. IL-7 and autologous mature dendritic cells (mDCs) induced CD57− cell proliferation. In contrast, mDCs, but not IL-7, induced CD57+ cell proliferation. This study establishes the relationship between age and thymic output during T cell homeostatic repopulation after alemtuzumab induction. Trial Registration: ClinicalTrials.gov - NCT00565773.
AB - Thymic output and homeostatic mature cell proliferation both influence T cell repopulation following depletional induction, though the relative contribution of each and their association with recipient age have not been well studied. We investigated the repopulating T cell kinetics in kidney transplant recipients who underwent alemtuzumab induction followed by belatacept/rapamycin-based immunosuppression over 36-month posttransplantation. We focused specifically on the correlation between repopulating T cell subsets and the age of patients. Substantial homeostatic Ki67-expressing T cell proliferation was seen posttransplantation. A repertoire enriched for naïve T (TNaïve) cells emerged posttransplantation. Analysis by generalized estimating equation linear models revealed a strong negative linear association between reconstituting TNaïve cells and advancing age. A relationship between age and persistence of effector memory cells was shown. We assessed thymic output and found an increase in the frequency of recent thymic emigrants (RTEs, CD4+CD31+) at 12-month posttransplantation. Patients under 30 years of age showed significantly higher levels of CD4+CD31+ cells than patients over 55 years of age pre- and posttransplantation. IL-7 and autologous mature dendritic cells (mDCs) induced CD57− cell proliferation. In contrast, mDCs, but not IL-7, induced CD57+ cell proliferation. This study establishes the relationship between age and thymic output during T cell homeostatic repopulation after alemtuzumab induction. Trial Registration: ClinicalTrials.gov - NCT00565773.
KW - basic (laboratory) research/science
KW - clinical research/practice
KW - immunobiology
KW - immunosuppressant - fusion proteins and monoclonal antibodies: alemtuzumab
KW - immunosuppressant - fusion proteins and monoclonal antibodies: belatacept
KW - immunosuppression/immune modulation
KW - immunosuppressive regimens - induction
KW - kidney transplantation/nephrology
KW - lymphocyte biology: differentiation/maturation
KW - lymphocyte biology: proliferation
UR - http://www.scopus.com/inward/record.url?scp=85106252848&partnerID=8YFLogxK
U2 - 10.1111/ajt.16625
DO - 10.1111/ajt.16625
M3 - Article
C2 - 33942491
AN - SCOPUS:85106252848
SN - 1600-6135
VL - 21
SP - 3163
EP - 3174
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 9
ER -